Mayura Shinde

728 total citations
31 papers, 506 citations indexed

About

Mayura Shinde is a scholar working on Pediatrics, Perinatology and Child Health, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mayura Shinde has authored 31 papers receiving a total of 506 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pediatrics, Perinatology and Child Health, 8 papers in Epidemiology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mayura Shinde's work include Pregnancy and Medication Impact (8 papers), Pregnancy and preeclampsia studies (6 papers) and Birth, Development, and Health (6 papers). Mayura Shinde is often cited by papers focused on Pregnancy and Medication Impact (8 papers), Pregnancy and preeclampsia studies (6 papers) and Birth, Development, and Health (6 papers). Mayura Shinde collaborates with scholars based in United States, Canada and United Kingdom. Mayura Shinde's co-authors include Peter H. Langlois, Jean D. Brender, Joseph R. Sharkey, Ann M. Vuong, Mark A. Canfield, John C. Huber, Joachim Griesenbeck, Paul A. Romitti, Katherine E. Kelley and Martha M. Werler and has published in prestigious journals such as PLoS ONE, American Journal of Epidemiology and Radiology.

In The Last Decade

Mayura Shinde

29 papers receiving 490 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mayura Shinde United States 14 121 74 70 60 53 31 506
Tyler R. McClintock United States 12 42 0.3× 135 1.8× 49 0.7× 73 1.2× 20 0.4× 20 531
C. Dunster United Kingdom 9 129 1.1× 104 1.4× 91 1.3× 23 0.4× 6 0.1× 11 493
Lijun Zhu China 18 183 1.5× 39 0.5× 179 2.6× 82 1.4× 49 0.9× 34 927
Xuming Mo China 17 100 0.8× 197 2.7× 73 1.0× 91 1.5× 71 1.3× 61 776
Citlalli Osorio-Yáñez Mexico 13 69 0.6× 317 4.3× 45 0.6× 40 0.7× 14 0.3× 28 512
Daniel T. Dibaba United States 13 23 0.2× 26 0.4× 18 0.3× 129 2.1× 53 1.0× 23 676
Florencia Harari Sweden 19 90 0.7× 547 7.4× 26 0.4× 64 1.1× 23 0.4× 34 909
John Coakley Australia 16 141 1.2× 144 1.9× 36 0.5× 88 1.5× 21 0.4× 38 707
Ning Cheng China 18 39 0.3× 326 4.4× 21 0.3× 58 1.0× 41 0.8× 59 841
Yiming Pang China 14 53 0.4× 254 3.4× 73 1.0× 46 0.8× 14 0.3× 34 500

Countries citing papers authored by Mayura Shinde

Since Specialization
Citations

This map shows the geographic impact of Mayura Shinde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mayura Shinde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mayura Shinde more than expected).

Fields of papers citing papers by Mayura Shinde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mayura Shinde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mayura Shinde. The network helps show where Mayura Shinde may publish in the future.

Co-authorship network of co-authors of Mayura Shinde

This figure shows the co-authorship network connecting the top 25 collaborators of Mayura Shinde. A scholar is included among the top collaborators of Mayura Shinde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mayura Shinde. Mayura Shinde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pérez-Vilar, Silvia, Sruthi Adimadhyam, Fatma M. Shebl, et al.. (2025). Cannabis-Related Healthcare Encounters Among U.S. Commercially Insured Adults. American Journal of Preventive Medicine. 70(3). 107936–107936.
2.
Shinde, Mayura, Jennifer G. Lyons, Maria E. Kempner, et al.. (2025). Characteristics and Medication Use Patterns of Pregnancies With COVID‐19 Ending in Live‐Birth in the Sentinel System. Pharmacoepidemiology and Drug Safety. 34(4). e70121–e70121.
3.
Lyons, Jennifer G., Mayura Shinde, Judith C. Maro, et al.. (2024). Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy. Drug Safety. 47(10). 931–940. 2 indexed citations
4.
Eworuke, Efe, Mayura Shinde, Laura Hou, et al.. (2024). Exposure to Valsartan Products Containing Nitrosamine Impurities in the United States, Canada, and Denmark. Pharmacoepidemiology and Drug Safety. 33(9). e5849–e5849. 1 indexed citations
5.
Eworuke, Efe, Mayura Shinde, Laura Hou, et al.. (2023). Valsartan, Losartan and Irbesartan use in the USA, UK, Canada and Denmark after the nitrosamine recalls: a descriptive cohort study. BMJ Open. 13(4). e070985–e070985. 13 indexed citations
6.
Fuller, Candace C., Mayura Shinde, Edward Rosen, et al.. (2023). Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021. PLoS ONE. 18(7). e0288284–e0288284. 2 indexed citations
7.
Taylor, Lockwood G., Steven T. Bird, Sengwee Toh, et al.. (2022). Utility of fertility procedures and prenatal tests to estimate gestational age for live‐births and stillbirths in electronic health plan databases. Pharmacoepidemiology and Drug Safety. 31(5). 534–545. 5 indexed citations
8.
Fuller, Candace C., Vinod E. Nambudiri, Lesley H. Curtis, et al.. (2021). Medical chart validation of inpatient diagnosis codes for transfusion‐related acute lung injury 2013‐2015. Transfusion. 61(3). 754–766. 5 indexed citations
9.
Andrade, Susan E., Mayura Shinde, Tiffany A. Moore Simas, et al.. (2021). Validation of an ICD‐10‐based algorithm to identify stillbirth in the Sentinel System. Pharmacoepidemiology and Drug Safety. 30(9). 1175–1183. 13 indexed citations
10.
Shinde, Mayura, Corinne Woods, Christina Y. Chang, et al.. (2021). Utilization of hydroxyprogesterone caproate among pregnancies with live birth deliveries in the sentinel distributed database. The Journal of Maternal-Fetal & Neonatal Medicine. 35(25). 6291–6296. 3 indexed citations
11.
Liu, Wei, Corinne Woods, Jie Li, et al.. (2020). Phosphodiesterase type 5 inhibitor use among pregnant and reproductive‐age women in the United States. Pharmacoepidemiology and Drug Safety. 30(2). 126–134. 6 indexed citations
12.
Huang, Ting‐Ying, Emily C. Welch, Mayura Shinde, et al.. (2019). Reproducing Protocol‐Based Studies Using Parameterizable Tools—Comparison of Analytic Approaches Used by Two Medical Product Surveillance Networks. Clinical Pharmacology & Therapeutics. 107(4). 966–977. 6 indexed citations
13.
Wallace, Anna, et al.. (2019). Detecting schizophrenia early: Prediagnosis healthcare utilization characteristics of patients with schizophrenia may aid early detection. Schizophrenia Research. 215. 392–398. 15 indexed citations
14.
Stephenson, Judith J., et al.. (2018). Comparison of claims vs patient-reported adherence measures and associated outcomes among patients with nonvalvular atrial fibrillation using oral anticoagulant therapy. Patient Preference and Adherence. Volume 12. 105–117. 27 indexed citations
15.
Weyer, Peter J., Jean D. Brender, Paul A. Romitti, et al.. (2014). Assessing bottled water nitrate concentrations to evaluate total drinking water nitrate exposure and risk of birth defects. Journal of Water and Health. 12(4). 755–762. 18 indexed citations
16.
Brender, Jean D., Mayura Shinde, F. Benjamin Zhan, Xi Gong, & Peter H. Langlois. (2014). Maternal residential proximity to chlorinated solvent emissions and birth defects in offspring: a case–control study. Environmental Health. 13(1). 96–96. 31 indexed citations
17.
Brender, Jean D., Peter J. Weyer, Paul A. Romitti, et al.. (2013). Prenatal Nitrate Intake from Drinking Water and Selected Birth Defects in Offspring of Participants in the National Birth Defects Prevention Study. Environmental Health Perspectives. 121(9). 1083–1089. 113 indexed citations
18.
Huber, John C., Jean D. Brender, Qi Zheng, et al.. (2013). Maternal dietary intake of nitrates, nitrites and nitrosamines and selected birth defects in offspring: a case-control study. Nutrition Journal. 12(1). 34–34. 21 indexed citations
19.
Brender, Jean D., Martha M. Werler, Mayura Shinde, et al.. (2012). Nitrosatable drug exposure during the first trimester of pregnancy and selected congenital malformations. Birth Defects Research Part A Clinical and Molecular Teratology. 94(9). 701–713. 26 indexed citations
20.
Brender, Jean D., Martha M. Werler, Katherine E. Kelley, et al.. (2011). Nitrosatable Drug Exposure During Early Pregnancy and Neural Tube Defects in Offspring. American Journal of Epidemiology. 174(11). 1286–1295. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026